Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial Dewilde W, Janssen P, Kelder J, Verheugt F, de Smet B, Adrianssens T, Vrolix M, Brueren G, Vandendriessche T, Van Mieghem C, Cornelis K, Vos J, Breet N, ten Berg J August 20, 2015 | 10.4244/EIJY14M06_07
Cost-effectiveness of contemporary vascular closure devices for the prevention of vascular complications after percutaneous coronary interventions in an all-comers PCI population Kerré S, Kustermans L, Vandendriessche T, Bosmans J, Haine S, Miljoen H, Vrints C, Beutels P, Wouters K, Claeys M June 20, 2014 | 10.4244/EIJV10I2A32
New issue EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more (3D volume-rendered CCTA LAA example) January 17, 2020
Editorial From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology” Robert Byrne January 17, 2020
JAA New this week: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more January 21, 2020
TRIALS BOOK Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ... (The Trials book is supported by Biotronik) January 15, 2020
JAA Last week's JAA's: Inferior caval valve implantation for severe tricuspid regurgitation January 14, 2020
